Search

Search Results

• Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

  M.G. Portuesi, P. Perosa

  61-63

  https://doi.org/10.4081/reumatismo.2008.61

  1151

  PDF: 862

• Anti-chromatin antibodies in juvenile rheumatoid arthritis

  F. Ingegnoli, N. Del Papa, E. Lupi, D.P. Comina, W. Maglione, V. Gerloni, F. Fantini

  240-244

  https://doi.org/10.4081/reumatismo.2003.240

  1203

  PDF: 967
• 

  Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study)

  E. Cárdenas-Cloud, A.J.L. Brambila-Tapia, R.M. Meda-Lara, F.d.J. Pérez-Vázquez, E. Chavarría-Ávila, F.J. Romero-Abundis, M. Vázquez-del-Mercado

  22-11-2021

  https://doi.org/10.4081/reumatismo.2021.1400

  2484

  PDF: 646

• Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience

  M. Taraborelli, L. Andreoli, S. Archetti, M. Ferrari, R. Cattaneo, A. Tincani

  98-106

  https://doi.org/10.4081/reumatismo.2009.98

  1226

  PDF: 1113
• 

  The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis

  S. Parisi, A. Bortoluzzi, G.D. Sebastiani, F. Conti, R. Caporali, N. Ughi, I. Prevete, A. Ariani, M. Manara, G. Carrara, C.A. Scirè

  22-49

  23-09-2019

  https://doi.org/10.4081/reumatismo.2019.1202

  7860

  PDF: 2354

• Knee radiosynovectomy with Y90 in patients with rheumatoid arthritis: our experiences

  W. Troise Rioda, A. Nervetti, G. Ugolotti, G. Adorni

  206-211

  https://doi.org/10.4081/reumatismo.2008.206

  1059

  PDF: 1811

• Assessment of circadian rhythm in pain and stiffness in rheumatic diseases according the EMA (Ecologic Momentary Assessment) method: patient compliance with an electronic diary

  F. Salaffi, A. Stancati, R. Procaccini, F. Cioni, W. Grassi

  238-249

  https://doi.org/10.4081/reumatismo.2005.238

  1553

  PDF: 1467

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  https://doi.org/10.4081/reumatismo.2008.290

  2048

  PDF: 1057

• TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

  I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

  275-282

  https://doi.org/10.4081/reumatismo.2006.275

  1017

  PDF: 928

• Therapeutic gene transfer for rheumatoid arthritis

  M.C. Boissier, N. Bessis

  51-61

  https://doi.org/10.4081/reumatismo.2004.1s.51

  698

  PDF: 691

• TNF-α gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-α agents: preliminary results

  M. Fabris, E. Di Poi, S. Sacco, G. Damante, L. Sinigaglia, G. Ferraccioli

  19-26

  https://doi.org/10.4081/reumatismo.2002.19

  1265

  PDF: 739
• 

  Thermal alterations in patients with inflammatory diseases: a comparison between psoriatic and rheumatoid arthritis

  A. Capo, J. Di Paolo, E. Celletti, E. Ismail, A. Merla, P. Amerio

  225-231

  20-12-2018

  https://doi.org/10.4081/reumatismo.2018.1050

  1461

  PDF: 969

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  https://doi.org/10.4081/reumatismo.2010.101

  1649

  PDF: 991

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  https://doi.org/10.4081/reumatismo.2006.121

  1722

  PDF: 1683

• Accuracy and standardization of diagnostic methods for the detection of antibodies to citrullinated peptides

  N. Bizzaro, M. Tampoia

  222-228

  https://doi.org/10.4081/reumatismo.2009.222

  1060

  PDF: 850

• Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

  G. Ferraccioli

  46-50

  https://doi.org/10.4081/reumatismo.2004.1s.46

  686

  PDF: 672

• Role of chemokines in the pathogenesis of rheumatoid synovitis

  F. Ingegnoli, A. Manzo, F. Fantini, R. Caporali, C. Montecucco, N. Pipitone, C. Pitzalis

  12-18

  https://doi.org/10.4081/reumatismo.2002.12

  759

  PDF: 802

• Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

  M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

  41-49

  https://doi.org/10.4081/reumatismo.2008.41

  1154

  PDF: 772
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1329

  3712

  PDF: 523

• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini

  107-117

  https://doi.org/10.4081/reumatismo.2009.107

  1887

  PDF: 1118

• Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity

  E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli

  16-21

  https://doi.org/10.4081/reumatismo.2005.16

  941

  PDF: 840
• 

  Poncet’s disease diagnostic criteria decodes conundrum: Poncet’s vs pseudo Poncet’s

  V. Shobha, A.M. Desai

  46-50

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1114

  1577

  PDF: 1086
• 

  Sjögren’s syndrome and mean platelet volume

  M. E. Tezcan, Ş. Demir, M. Sargın, M. Aliustaoğlu, B. Göker

  33-34

  30-06-2015

  https://doi.org/10.4081/reumatismo.2015.752

  1311

  PDF: 1084

• Current therapeutic strategies for HCV-associated cryoglobulinemia

  F. Iannuzzella, G. Garini

  163-173

  https://doi.org/10.4081/reumatismo.2008.163

  1027

  PDF: 1993
• 

  Translation and cross-cultural adaptation into Italian of the self-administered FLARE-RA questionnaire for rheumatoid arthritis

  N. Ughi, T. Schioppo, I. Scotti, V. Merlino, A. Murgo, O. De Lucia, B. Fautrel, F. Guillemin, R. Christensen, F. Ingegnoli

  21-30

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1230

  1155

  PDF: 717
• 

  A short history of anti-rheumatic therapy - VII. Biological agents

  G. Pasero, P. Marson, B. Gatto

  185-194

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.185

  1484

  PDF: 1219

• Dynamic contrast-enhanced magnetic resonance imaging of the wrist in early arthritis

  G. Zamogna, M. Parodi, B. Bartolini, D. Schettini, G. Minetti, M. D'Auria, E. Silvestri, G. Garlaschi, M.A. Cimmino

  254-259

  https://doi.org/10.4081/reumatismo.2008.254

  1107

  PDF: 821
• 

  Clinical features and genetic biomarkers associated with different phenotypes of systemic lupus erythematosus in Paraguayan patients

  I. Acosta-Colman, Z. Morel, A. Ayala Lugo, V. Jolly, I. de Guillén, P. Langjahr, M. Vazquez, M.T Martínez de Filártiga, M.E. Acosta

  17-07-2023

  https://doi.org/10.4081/reumatismo.2023.1541

  958

  PDF: 568
• 

  Histopathology of the skin in rheumatic diseases

  M.S. Chimenti, A. Di Stefani, P. Conigliaro, A. Saggini, S. Urbani, A. Giunta, M. Esposito, L. Bianchi, K. Peris, R. Perricone

  187-198

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1049

  3003

  PDF: 1817

• Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)”

  M. Mosca, C. Tani, C. Neri, A. Della Rossa, C. Baldini, R. Talarico, L. Carli, S. Bombardieri

  35-40

  https://doi.org/10.4081/reumatismo.2008.35

  1804

  PDF: 1524

• Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 italian patients

  C. Cervini, G. Leardini, A. Mathieu, L. Punzi, R. Scarpa

  283-290

  https://doi.org/10.4081/reumatismo.2005.283

  1675

  PDF: 2007

• Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases

  P. Grypiotis, A. Ruffatti, M. Tonello, C. Winzler, C. Radu, S. Zampieri, M. Favaro, A. Calligaro, S. Todesco

  232-237

  https://doi.org/10.4081/reumatismo.2002.232

  1609

  PDF: 5903

• Early rheumatoid arthritis: a prospective study on how to induce the remission

  T. Ziglioli, C. Bazzani, M. Filippini, S. Zingarelli, A. Giugno, R. Gorla

  131-135

  https://doi.org/10.4081/reumatismo.2008.131

  1003

  PDF: 676

• HAQ-DI Italian version in systemic sclerosis

  G. La Montagna, G. Cuomo, I. Chiarolanza, L. Ruocco, G. Valentini

  112-115

  https://doi.org/10.4081/reumatismo.2006.112

  1518

  PDF: 1937
• 

  Frequency of ANA/DFS70 autoantibodies in Colombian patients with undifferentiated connective tissue disease

  D. Rincón-Riaño, D.G. Fernández-Ávila, D. Acero-Molina, J.M. Bello Gualtero , C. Romero-Sánchez

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1420

  1400

  PDF: 791

• Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies

  A. Spadaro, M.L. Sorgi, R. Scrivo, A. Picarelli, M. Di Tola, L. Sabbatella, E. Taccari

  344-350

  https://doi.org/10.4081/reumatismo.2002.344

  1075

  PDF: 1637
• 

  Diagnostic and prognostic role of renal histopathology in rheumatic diseases

  F. Saccon, M. Gatto, M. Larosa, F. Ometto, M. Felicetti, R. Padoan, M. Zen

  165-177

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1064

  2220

  PDF: 1554

• How to prescribe physical exercise in rheumatology

  S. Maddali Bongi, A. Del Rosso

  4-11

  https://doi.org/10.4081/reumatismo.2010.4

  4131

  PDF: 3007

• Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes

  M. Fabris, L. Quartuccio, V. De Re, G. Pozzato, C. Mazzaro, A. Tavoni, C. Ferri, S. Salvin, A. Lerussi, C. Fabro, S. Bombardieri, S. De Vita

  28-34

  https://doi.org/10.4081/reumatismo.2008.28

  1467

  PDF: 628

• Association between Serum Amiloid A (SAA) in salivary glands and high levels of circulating β2-microglobulin in patients with Sjögren syndrome

  M. Benucci, F. Li Gobbi, A. Del Rosso, G. Gambacorta, A. Mannoni

  98-101

  https://doi.org/10.4081/reumatismo.2003.98

  973

  PDF: 996
• 

  Observations about subcalcaneal adventitial bursitis (heel fat pad inflammatory lesion) in rheumatoid arthritis. Comment on the article of Suzuki and Shirai

  P. Falsetti, E. Conticini, C. Baldi, C. Acciai, R. D'Alessandro, M. Bardelli, L. Cantarini, B. Frediani

  182-183

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1282

  704

  PDF: 614

• Farmacoeconomic impact of anti-TNFα

  G. Leardini, C. Bernardi, E. Vaccaro

  80-86

  https://doi.org/10.4081/reumatismo.2004.1s.80

  829

  PDF: 641

• BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity

  M. Vadacca, D. Margiotta, D. Sambataro, F. Buzzulini, M. Lo Vullo, A. Rigon, A. Afeltra

  259-265

  https://doi.org/10.4081/reumatismo.2010.259

  1868

  PDF: 2067

• Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases

  C. Sales, F. Oliviero, P. Spinella

  95-101

  https://doi.org/10.4081/reumatismo.2008.95

  2536

  PDF: 1782

• Pulmonary hypertension in autoimmune rheumatic diseases

  B. Marasini, M. Massarotti, R. Cossutta, L. Massironi, A. Mantero

  114-118

  https://doi.org/10.4081/reumatismo.2005.114

  873

  PDF: 2726

• Detection of serum anti-B/B’ UsnRNP antibodies in patients with connective tissue diseases by immunoblotting

  A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, L. Iaccarino, R. Bendo, P.F. Gambari

  324-330

  https://doi.org/10.4081/reumatismo.2002.324

  881

  PDF: 2667

• Magnetic resonance imaging of the joints: a revolution for the practicing rheumatologist

  M.A. Cimmino

  239-241

  https://doi.org/10.4081/reumatismo.2008.239

  994

  PDF: 658

• Are there any positive effects of TNF-alpha blockers on bone metabolism?

  B. Seriolo, S. Paolino, A. Sulli, M. Cutolo

  199-205

  https://doi.org/10.4081/reumatismo.2006.199

  1219

  PDF: 1127

• Septic arthritis: what is the role for the rheumatologist?

  F. Schiavon, M. Favero, V. Carraro, L. Riato

  1-5

  https://doi.org/10.4081/reumatismo.2008.1

  1207

  PDF: 1429
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1289

  1601

  PDF: 993